Search Results
Search results for "Chris Tate"
Results found for "Chris Tate"
- 4GPCRnet - International Symposium
DFG-funded CRC1423 and RU2372) have joined forces to organize an international meeting, which will take The event will take place in the heart of Leipzig, which offers a colorful mixture of culture and vivid
- First AMA of 2026: GPCR Pharmacology, Biased Signaling & Mechanistic Clarity
Biased Signaling & Assay Interpretation The first GPCR Pharmacology AMA of 2026 Ā at Terryās Corner will take
- Why Opposing Processes Matter for Your Next GPCR Drug
dual action on beta and alpha receptors, for example, invites reflex bradycardia that blunts its heart rate Terry illustrates this with classic β-receptor partial agonists, showing how heart rate set-points under
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
time can reshape how you evaluate and advance lead compounds, potentially saving your team from costly late-stage Threat Avoided: Ā Prevent costly late-stage failures by incorporating kinetic modeling early in your pipeline
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
Cam Sinh Lu GPCR-BSD: a database of binding sites of human G-protein coupled receptors under diverse states GPCR Function GPCR-BSD: a database of binding sites of human G-protein coupled receptors under diverse states
- The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor
Although studies have focused on the G-protein signaling state, the mechanism for β-arrestin signaling
- Residency time of agonists does not affect the stability of GPCR-arrestin complexes
Here, we ask the question whether agonists with very slow off-rates can cause the formation of particularly
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
I would like to take this opportunity to thank all our French partners who trust us in the generation
- š° GPCR Weekly News, April 1 to 7, 2024
Please completeĀ this formĀ to take advantage of this opportunity. If you've participated in our symposiums, please take a few minutes to completeĀ this survey.
- Specific Functions of Melanocortin 3 Receptor (MC3R)
coupled receptor (GPCR) that is defined as a regulator of appetite/hunger balance mechanisms mostly up to date
- ChemoCentryx Announces EU Approval of TAVNEOSĀ® (avacopan) for the Treatment of ANCA-Associated ...
TAVNEOS will receive marketing authorization in all member states of the European Union, as well as in
- Molecular insights into psychedelic drug action
With the United States Food and Drug Administration's designation of psilocybin as a "Breakthrough Therapy
- MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?
processes and regulation of a wide range of immune responses in different physiologic and pathologic states
- Understanding Orthosteric Binding: The Key to Drug Action
Importance of Binding in Drug Action In pharmacology, binding must happen before any drug effect can take
- Emerging approaches for decoding neuropeptide transmission
well as the conditions in which neuropeptides directly mediate physiological and adaptive behavioral states
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
What will students gain from taking this course? Take action immediately to join our esteemed learning community!
- Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype
the most important of the aforementioned ligands, highlight their properties and exhibit the current state-of-the-art
- John Streicher talks about his work on terpenes found in cannabis as these may be a novel way to ...
without the negative side effects "Many people are familiar with cannabis, but John Streicher, PhD, takes
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
We review the current state of CB2 ligand development and progress in optimising physicochemical properties
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
We review the current state of CB2 ligand development and progress in optimizing physicochemical properties
- Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
New high-resolution structures of CB1 receptor in different functional states have significantly improved
- š° GPCR Weekly News, May 22 to 28, 2023
Receptor Activation in ChemokineāChemokine Receptor Complexes Industry News Mavorixafor reduces infection rates among patients with WHIM syndrome Bristol Myers Squibbās Investigational LPA1 Antagonist Reduces the Rate
- From DNA day to GPCR genomics
In the United States, DNA Day was officially celebrated on April 25th, 2003. United States. https://www.genome.gov/ Dixon, R. A., Kobilka, B. K., Strader, D. J., Benovic, J.
- Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
HLGR2 RNAi led to a low pupation rate (45.00%), body malformation, abnormal wing expansion, failed cuticle melanization (63.33%), and high mortality rate (48.33%).
- CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse
We also take into account the detrimental effect of mutations carried by distinct signalling proteins
- High hedgehog signaling is transduced by a multikinase-dependent switch controlling the...
We provide evidence that HH promotes the stabilization of SMO by switching its fate after endocytosis
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
present two cryo-electron microscopy structures of CX3CR1-Gi1 complexes in ligand-free and CX3CL1-bound states
- Molecular insights into regulation of constitutive activity by RNA editing 5HT2C serotonin receptor
elucidate the molecular mechanisms responsible for these effects of RNA editing, we present four active-state
- Profiling Immune Cell and Platelet Transcriptomes
sensitive manner also opens doors for exploring the roles of these receptors in various pathological states
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
key findings of GPCR in the cochlea and discuss the role of GPCR in the cochlea, such as stem cell fate







